Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1995 1
1996 1
1997 1
2001 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
SMARCA4 as a support for the differential diagnosis of poorly differentiated lung carcinomas.
Panozzi M, Alì G, Proietti A, Melfi F, Zirafa CC, Lucchi M, Fontanini G. Panozzi M, et al. Pathologica. 2023 Jun;115(3):164-171. doi: 10.32074/1591-951X-847. Pathologica. 2023. PMID: 37387441 Free PMC article.
They are rare tumours with a poor prognosis, classified into three subgroups, namely pleomorphic carcinoma, pulmonary blastoma and carcinosarcoma. In the 5th edition of WHO Classification of Thoracic Tumours more space is given to SMARC4-deficient lung cancers. ...
They are rare tumours with a poor prognosis, classified into three subgroups, namely pleomorphic carcinoma, pulmonary blastoma
Primary sarcomas of the lung.
Suster S. Suster S. Semin Diagn Pathol. 1995 May;12(2):140-57. Semin Diagn Pathol. 1995. PMID: 7638447 Review.
Primary pulmonary sarcomas are rare tumors. Because the lung is one of the favored metastatic sites for soft tissue sarcomas, care must be taken when evaluating these lesions to rule out the possibility of an alternate primary source by means of thorough clinical hi …
Primary pulmonary sarcomas are rare tumors. Because the lung is one of the favored metastatic sites for soft tissue sarcomas, care
Management of pulmonary blastoma in children.
Calabria R, Srikanth MS, Chamberlin K, Bloch J, Atkinson JB. Calabria R, et al. Am Surg. 1993 Mar;59(3):192-6. Am Surg. 1993. PMID: 8476159
Pulmonary blastoma is a rare neoplasm, accounting for 0.5 per cent of all primary malignant pulmonary tumors. The clinical features, radiologic findings, and management of five children with pulmonary blastoma are described. The female/male rati
Pulmonary blastoma is a rare neoplasm, accounting for 0.5 per cent of all primary malignant pulmonary tumors. The clini
Small round cell tumors of the abdomen and thorax. Role of fine needle aspiration cytologic features in the diagnosis and differential diagnosis.
Das DK, Bhambhani S, Chachra KL, Murthy NS, Tripathi RP. Das DK, et al. Acta Cytol. 1997 Jul-Aug;41(4):1035-47. doi: 10.1159/000332785. Acta Cytol. 1997. PMID: 9250296
RESULTS: The 59 cases of small round cell tumors included 5 cases of neuroblastoma, 7 of hepatoblastoma, 4 of nephroblastoma, 1 of pulmonary blastoma, 2 of Ewing's sarcoma, 23 of non-Hodgkin's lymphoma (NHL), 15 of small cell anaplastic carcinoma (SCAC), 1 NHL/SCAC …
RESULTS: The 59 cases of small round cell tumors included 5 cases of neuroblastoma, 7 of hepatoblastoma, 4 of nephroblastoma, 1 of pulmon
Intraoperative high-dose-rate brachytherapy for the treatment of pediatric tumors: the Ohio State University experience.
Nag S, Tippin D, Ruymann FB. Nag S, et al. Int J Radiat Oncol Biol Phys. 2001 Nov 1;51(3):729-35. doi: 10.1016/s0360-3016(01)01697-2. Int J Radiat Oncol Biol Phys. 2001. PMID: 11597815
RESULTS: After a median follow-up of 47 months (range 12-97), 11 patients were alive and without evidence of disease (overall survival rate 85%, 4-year actuarial survival rate 77%). Of the 2 who died, 1 had Stage III pulmonary blastoma with a sacral recurrence; the …
RESULTS: After a median follow-up of 47 months (range 12-97), 11 patients were alive and without evidence of disease (overall survival rate …